SMALL NONCLEAVED CELL LYMPHOMA IN ADULTS - SUPERIOR RESULTS FOR STAGES I-III DISEASE (VOL 8, PG 615, 1993)

被引：0
作者：
LOPEZ, TM
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 1994年 / 12卷 / 03期
关键词：
D O I：
10.1200/JCO.1994.12.3.646
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：646 / 646
页数：1
相关论文
共 50 条
  • [21] The Attitude towards Polypills Questionnaire (APPQ): a phase I-III development and validation study in patients with cerebrovascular disease (vol 28, pg 4039, 2021)
    Lehmann
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 (05) : 1550 - 1551
  • [22] Galectin-9-based immune risk score model helps to predict relapse in stage I-III small cell lung cancer (vol 8, e001391, 2020)
    Chen, P.
    Zhang, L.
    Zhang, W.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (11)
  • [23] Factors Affecting the Risk of Brain Metastasis in Small Cell Lung Cancer With Surgery: Is Prophylactic Cranial Irradiation Necessary for Stage I-III Disease?
    Gong, Linlin
    Wang, Q. I.
    Zhao, Lujun
    Yuan, Zhiyong
    Li, Ruijian
    Wang, Ping
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (01): : 196 - 200
  • [24] The prevalence of key oncogenic driver mutations in stage I-III non-small cell lung cancer: Results from the AACR GENIE BPC dataset
    Zu, Ke
    Ma, Jiemin
    Chen, Cai
    Pierce, Christine
    CANCER RESEARCH, 2024, 84 (06)
  • [25] Expression of Ribonucleotide Reductase Subunit-2 and Thymidylate Synthase Correlates with Poor Prognosis in Patients with Resected Stages I-III Non-Small Cell Lung Cancer
    Grossi, Francesco
    Dal Bello, Maria Giovanna
    Salvi, Sandra
    Puzone, Roberto
    Pfeffer, Ulrich
    Fontana, Vincenzo
    Alama, Angela
    Rijavec, Erika
    Barletta, Giulia
    Genova, Carlo
    Sini, Claudio
    Ratto, Giovanni Battista
    Taviani, Mario
    Truini, Mauro
    Merlo, Domenico Franco
    DISEASE MARKERS, 2015, 2015
  • [26] ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy
    Lebow, Emily S.
    Shaverdian, Narek
    Eichholz, Jordan E.
    Kratochvil, Leah B.
    Mccune, Megan
    Murciano-Goroff, Yonina R.
    Jee, Justin
    Eng, Juliana
    Chaft, Jamie E.
    Kris, Mark G.
    Kalashnikova, Ekaterina
    Feeney, Jordan
    Scalise, Carly Bess
    Sudhaman, Sumedha
    Palsuledesai, Charuta C.
    Malhotra, Meenakshi
    Krainock, Michael
    Sethi, Himanshu
    Aleshin, Alexey
    Liu, Minetta C.
    Shepherd, Annemarie F.
    Wu, Abraham J.
    Simone, Charles B.
    Gelblum, Daphna Y.
    Johnson, Kaylie A.
    Rudin, Charles M.
    Gomez, Daniel R.
    Razavi, Pedram
    Reis-Filho, Jorge S.
    Isbell, James M.
    Li, Bob T.
    Rimner, Andreas
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Development of a nomogram combining clinical staging with 18F-FDG PET/CT image features in non-small-cell lung cancer stage I-III (vol 43, pg 1477, 2016)
    Desseroit, Marie-Charlotte
    Visvikis, Dimitris
    Tixier, Florent
    Majdoub, Mohamed
    Perdrisot, Remy
    Guillevin, Remy
    Le Rest, Catherine Cheze
    Hatt, Mathieu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (10) : 1933 - 1933
  • [28] Real-World Effectiveness and Prognostic Factors Analysis of Stages I-III Non-Small Cell Lung Cancer Following Neoadjuvant Chemo-Immunotherapy or Neoadjuvant Chemotherapy
    Liu, Zuo
    Gao, Zhaoming
    Zhang, Mengzhe
    Wang, Xiaofei
    Gong, Jialin
    Jiang, Shuai
    Zhang, Zhenfa
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 28 (02) : 111 - 120
  • [29] Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I-III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial (vol 19, 8435, 2023)
    Altorki, Nasser K.
    Walsh, Zachary H.
    Melms, Johannes C.
    Port, Jeffery L.
    Lee, Benjamin E.
    Nasar, Abu
    Spinelli, Cathy
    Caprio, Lindsay
    Rogava, Meri
    Ho, Patricia
    Christos, Paul J.
    Saxena, Ashish
    Elemento, Olivier
    Bhinder, Bhavneet
    Ager, Casey
    Amin, Amit Dipak
    Sanfilippo, Nicholas J.
    Mittal, Vivek
    Borczuk, Alain C.
    Formenti, Silvia C.
    Izar, Benjamin
    McGraw, Timothy E.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [30] Trends and variations in the treatment of stage I-III small cell lung cancer from 2008 to 2019: A nationwide population-based study from the Netherlands (VOL 162C, PG 61, 2021)
    Evers, Jelle
    Hendriks, Lizza E. L.
    De Jaeger, Katrien
    Wijsman, Robin
    Dirk, De Ruysscher
    Terhaard, Chris
    Van der Sangen, Maurice
    Siesling, Sabine
    Struikmans, Henk
    Aarts, Mieke J.
    LUNG CANCER, 2022, 167
12345